ROSEMONT, Ill.--(BUSINESS WIRE)--Proteintech, a global leader in antibodies and life science solutions, is excited to announce additional product characterization for primary antibody targets on its ...
ROSEMONT, Ill., September 02, 2025--(BUSINESS WIRE)--Proteintech, a global leader in antibodies and life science solutions, today announced the launch of Able AI, a first-of-its-kind artificial ...
New office and laboratory expansions enable Proteintech to accelerate growth in R&D, product development, production and customer support ROSEMONT, Ill.--(BUSINESS WIRE)--Proteintech, the benchmark in ...
In an industry first, Proteintech has unveiled Able AI, an artificial intelligence (AI) platform designed specifically to assist scientists in selecting research reagents and optimizing experimental ...
insights from industryDr. Karolina SzczesnaProduct Manager and Technical SupportProteintech An interview with Dr. Karolina Szczesna from Proteintech at SfN 2018, discussing the tell-tale signs of a ...
Proteintech Group, an original manufacturer of antibodies, nanobodies and recombinant proteins, today announced that it has made a strategic investment in Active Motif, a life science tools company ...
ROSEMONT, Ill. & SINGAPORE--(BUSINESS WIRE)--#Proteintech--Proteintech, the benchmark in antibodies, Nanobodies, and cytokines & growth factors, today announces the opening of its new Singapore office ...
With this certification, Proteintech’s HumanKine® Human cell-expressed cytokines and growth factors are now available in GMP-compliant versions for use in clinical trials and commercial manufacturing.
The 3D Epitope Mapping is a state-of-the-art solution that utilizes a combination of experimental techniques, including peptide scanning and microbial display, aiming to precisely map the antibody ...
Proteintech, announced the launch of Able AI, a first-of-its-kind artificial intelligence tool that is now available on (ptglab.com). This capability reduces guesswork and trial-and-error, enabling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results